PURPOSE: Taurine, the major intracellular free amino acid found in high concentrations in mammalian cells, is known to be an endogenous antioxidant and a membrane-stabilizing agent. It was hypothesized that taurine may be effective in reducing ischemia-reperfusion injury after lung transplantation and an experimental study was conducted in a rat model. METHODS: The number of Sprague-Dawley rats used in the study was 35. Animals were randomized into five groups of 7 rats each, including control, donor I, donor II, ischemia-reperfusion injury, and treatment groups. All animals were exposed to the same experimental conditions in the preoperative period. Rats were fixed in a supine position after the induction. After the rats were shaved, a left pneumonectomy was performed following sternotomy in control, donor I, and donor II groups. The harvested grafts in donor I and donor II groups were transplanted to the rats of the ischemia-reperfusion group and treatment group, respectively. However, taurine was administered intraperitoneally for 3 days before the harvesting procedure in donor II. All harvested lungs were kept in a Euro-Collins solution at +4 °C for 24 h in a half-inflated manner. After harvesting and transplantation, lungs were sampled for histopathological and biochemical analysis. RESULTS: Malondialdehyde and superoxide dismutase, glutathione peroxidase, and catalase levels were lower in the treatment group than the other groups (p < 0.05). Histopathological findings were better in treatment group than the ischemia-reperfusion group (p < 0.05). CONCLUSION: It was demonstrated that donor treatment with taurine resulted in preservation of transplanted lung tissue in respect to histopathological and biochemical findings.
PURPOSE:Taurine, the major intracellular free amino acid found in high concentrations in mammalian cells, is known to be an endogenous antioxidant and a membrane-stabilizing agent. It was hypothesized that taurine may be effective in reducing ischemia-reperfusion injury after lung transplantation and an experimental study was conducted in a rat model. METHODS: The number of Sprague-Dawley rats used in the study was 35. Animals were randomized into five groups of 7 rats each, including control, donor I, donor II, ischemia-reperfusion injury, and treatment groups. All animals were exposed to the same experimental conditions in the preoperative period. Rats were fixed in a supine position after the induction. After the rats were shaved, a left pneumonectomy was performed following sternotomy in control, donor I, and donor II groups. The harvested grafts in donor I and donor II groups were transplanted to the rats of the ischemia-reperfusion group and treatment group, respectively. However, taurine was administered intraperitoneally for 3 days before the harvesting procedure in donor II. All harvested lungs were kept in a Euro-Collins solution at +4 °C for 24 h in a half-inflated manner. After harvesting and transplantation, lungs were sampled for histopathological and biochemical analysis. RESULTS:Malondialdehyde and superoxide dismutase, glutathione peroxidase, and catalase levels were lower in the treatment group than the other groups (p < 0.05). Histopathological findings were better in treatment group than the ischemia-reperfusion group (p < 0.05). CONCLUSION: It was demonstrated that donor treatment with taurine resulted in preservation of transplanted lung tissue in respect to histopathological and biochemical findings.
Authors: Peter Schemmer; Rui Liang; Marius Kincius; Christa Flechtenmacher; Hartwig Bunzendahl; Carsten N Gutt; Arianeb Mehrabi; Martha-Maria Gebhard; Markus W Büchler; Thomas W Kraus Journal: Liver Transpl Date: 2005-08 Impact factor: 5.799
Authors: Yuchuan Huang; Juan Shan; Chuan'en Wang; Jie Ma; Dan Li; Li Li; Shengfu Li; Youping Li Journal: Transpl Immunol Date: 2008-08-30 Impact factor: 1.708
Authors: Xiaohai Guan; Genevieve Dei-Anane; Rui Liang; Marie-Luise Gross; Arash Nickkholgh; Michael Kern; Jochen Ludwig; Martin Zeier; Markus W Büchler; Jan Schmidt; Peter Schemmer Journal: J Surg Res Date: 2007-07-25 Impact factor: 2.192
Authors: M Kincius; R Liang; A Nickkholgh; K Hoffmann; C Flechtenmacher; E Ryschich; C N Gutt; M-M Gebhard; J Schmidt; M W Büchler; P Schemmer Journal: Eur Surg Res Date: 2007-05-22 Impact factor: 1.745
Authors: Niels Dreyer; Christian Mühlfeld; Antonia Fehrenbach; Thomas Pech; Sebastian von Berg; Ragi Nagib; Joachim Richter; Thorsten Wittwer; Thorsten Wahlers; Matthias Ochs Journal: Respir Res Date: 2008-01-18
Authors: Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis Journal: Int J Oncol Date: 2020-07-14 Impact factor: 5.650
Authors: I Sukhotnik; I Aranovich; Y Ben Shahar; N Bitterman; Y Pollak; D Berkowitz; D Chepurov; A G Coran; A Bitterman Journal: Pediatr Surg Int Date: 2015-10-26 Impact factor: 1.827